Carey Insulating Cement

Product Description

Carey Insulating Cement was a refractory insulating cement manufactured by the Celotex Corporation under the Carey product line. Produced from approximately 1906 through 1967, this cement was formulated for high-temperature industrial applications where conventional materials could not withstand prolonged thermal stress. It was applied as a trowelable or hand-packed compound to boilers, furnaces, kilns, pipes, and other industrial equipment operating at elevated temperatures.

The product’s long production run reflects the broad industrial demand for reliable refractory materials throughout the first half of the twentieth century. Carey Insulating Cement was marketed to a wide range of heavy industrial sectors, including power generation, chemical processing, steel manufacturing, and other industries dependent on high-heat containment. Its formulation was designed to bond tightly to metal and masonry surfaces, resist thermal cycling, and maintain structural integrity under conditions that would cause ordinary cements to crack or fail.

The Carey product line itself has a complex corporate history. The W.H. Carey Company was among the early producers of asbestos-containing construction and industrial materials in the United States, and its products were eventually brought under the Celotex Corporation umbrella. Celotex, which itself became a significant figure in asbestos litigation, continued manufacturing Carey-branded insulating cements until production ceased in 1967.

Asbestos Content

Carey Insulating Cement contained chrysotile asbestos as a primary functional ingredient. Chrysotile, also known as white asbestos, is a serpentine-form fiber that was widely used in thermal insulation products because of its heat resistance, tensile strength, and binding properties. In refractory cements, chrysotile fibers provided structural reinforcement, helped the product resist cracking during thermal expansion and contraction, and contributed to the overall insulating performance of the finished application.

Chrysotile asbestos is regulated under the Occupational Safety and Health Administration (OSHA) asbestos standards and is classified as a known human carcinogen by the International Agency for Research on Cancer (IARC). Under the Asbestos Hazard Emergency Response Act (AHERA), all forms of asbestos—including chrysotile—are subject to strict identification, management, and abatement requirements when present in regulated settings.

The use of chrysotile in refractory insulating cements was standard industry practice for much of the twentieth century. Because chrysotile fibers are microscopic and become airborne when the material is disturbed, mixed, applied, or removed, any activity involving Carey Insulating Cement carried potential for significant fiber release.

How Workers Were Exposed

Industrial workers who handled, applied, or worked in proximity to Carey Insulating Cement faced exposure to airborne chrysotile asbestos fibers across multiple stages of the product’s use cycle. Exposure pathways were not limited to those workers who directly handled the cement; bystander exposure among workers in the same facility was also a documented concern in industrial settings.

Mixing and Preparation: Before application, insulating cement typically required mixing with water to achieve the correct consistency. This process disturbed dry cement powder, releasing asbestos fibers into the surrounding air. Workers involved in this stage faced concentrated fiber exposure without the protection of enclosure or effective respiratory controls that would not become standard for decades.

Application and Finishing: Workers who troweled, packed, or hand-applied the cement to boilers, pipes, furnaces, and kilns performed close, sustained work with the material. Application often required repeated handling and smoothing of the wet compound, and any drying or partially set cement that required reworking would release additional fibers.

Maintenance and Repair: Industrial equipment required ongoing maintenance, and insulating cement that had hardened over time became particularly hazardous when disturbed. Workers chipping, scraping, or removing old Carey Insulating Cement to prepare surfaces for reapplication generated substantial quantities of airborne fiber. These maintenance activities were common throughout the operational life of industrial facilities, meaning that exposure was not confined to the period when the product was actively being manufactured.

Bystander and General Industrial Exposure: Workers in the general vicinity of insulating cement application or removal—including pipefitters, boilermakers, millwrights, electricians, and general laborers—could inhale asbestos fibers without ever directly handling the product. In enclosed industrial environments with limited ventilation, fiber concentrations could remain elevated for extended periods.

Litigation records document that effective respiratory protection and industrial hygiene controls were not consistently provided to workers handling asbestos-containing insulating cements during much of the product’s production period. Plaintiffs in related cases have alleged that manufacturers, including Celotex, possessed or had access to information regarding the health hazards of asbestos exposure prior to the widespread implementation of protective measures, and that adequate warnings were not provided to workers or employers.

Documented Trust Fund / Legal Options

Carey Insulating Cement is classified as a Tier 2 litigated product. There is no dedicated asbestos bankruptcy trust fund established specifically for claims arising from Carey Insulating Cement or the Celotex Corporation’s Carey product line under terms that would currently process new claims through a trust mechanism in the standard fashion available to claimants with other manufacturer exposures.

Litigation History: Litigation records document that Celotex Corporation faced substantial asbestos-related personal injury litigation arising from its range of asbestos-containing products, including insulating cements sold under the Carey name. Plaintiffs alleged that chronic exposure to chrysotile asbestos fibers released from Carey Insulating Cement caused serious and life-threatening diseases, including mesothelioma, lung cancer, asbestosis, and other asbestos-related conditions.

Civil Litigation Pathway: Individuals diagnosed with an asbestos-related disease who have documented occupational exposure to Carey Insulating Cement may have grounds to pursue civil litigation. Product identification is central to building a viable claim, and legal counsel experienced in asbestos litigation can assist claimants in establishing exposure histories, identifying responsible parties, and navigating applicable statutes of limitations.

Other Trust Fund Eligibility: Workers who used or were exposed to Carey Insulating Cement often worked alongside other asbestos-containing products from multiple manufacturers. Many of those manufacturers have established asbestos bankruptcy trusts that do accept claims. A thorough occupational exposure history may support claims against multiple trusts for co-occurring exposures on the same job sites or within the same industrial facilities.

Consulting an Attorney: Anyone diagnosed with mesothelioma, lung cancer, asbestosis, or another asbestos-related disease who has a work history involving Carey Insulating Cement should consult a qualified asbestos attorney promptly. Statutes of limitations vary by state and typically begin running from the date of diagnosis or the date a claimant reasonably should have known of the connection between their illness and asbestos exposure.